Ozempic Lawsuits
5 articles on Ozempic Lawsuits, written by Shotlee and medically reviewed for clinical accuracy.
Why US Patients Sue Ozempic Makers Over Gastroparesis, Vision Loss
Lawsuits against Ozempic manufacturer Novo Nordisk are exploding in the US, with patients alleging the company hid severe side effects like gastroparesis and sudden vision loss from semaglutide. Originally a type 2 diabetes drug, Ozempic's popularity as a weight loss shot has sparked debates on safety and marketing. Despite high demand, experts urge medical supervision to avoid serious risks.
5 min read
Study: Wegovy Vision Loss Risk 5x Higher Than Ozempic
A groundbreaking study reveals Wegovy carries a fivefold higher risk of vision-threatening ischemic optic neuropathy compared to Ozempic. Analyzing millions of FDA reports, researchers link the risk to semaglutide's higher doses in Wegovy. Amid rising lawsuits, patients need to weigh benefits against potential eye health dangers.
5 min read
GLP-1 Side Effects & Lawsuits: What Users Must Know
GLP-1 medications like Ozempic and Wegovy have transformed weight management, but rising lawsuits highlight serious side effects like gastroparesis and vision loss. This guide breaks down the science, risks, and strategies for safe use. Learn how to monitor symptoms and integrate lifestyle changes effectively.
4 min read
Ozempic Weight Loss Boom: Rising Legal Risks
Semaglutide-based Ozempic has become a weight loss sensation beyond diabetes treatment. Yet, over 1,800 US lawsuits signal serious risks including gastroparesis, bowel issues, and vision loss from NAION. UK and Irish prescribers face growing negligence exposure.
2 min read
Ozempic Lawsuits Claim Drug Is Linked to Vision Loss
Ozempic, along with other weight loss medications, has demonstrated potential in mitigating health risks. However, lawsuits are emerging, alleging a connection between these drugs and vision loss. Patients are filing claims against the manufacturers.
2 min read